These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 30766534)

  • 1. PTX3 Polymorphisms Influence Cytomegalovirus Reactivation After Stem-Cell Transplantation.
    Campos CF; Leite L; Pereira P; Vaz CP; Branca R; Campilho F; Freitas F; Ligeiro D; Marques A; Torrado E; Silvestre R; Lacerda JF; Campos A; Cunha C; Carvalho A
    Front Immunol; 2019; 10():88. PubMed ID: 30766534
    [No Abstract]   [Full Text] [Related]  

  • 2. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants associated with cytomegalovirus infection after allogeneic hematopoietic cell transplantation.
    Casto AM; Seo S; Levine DM; Storer BE; Dong X; Hansen JA; Boeckh M; Martin PJ
    Blood; 2021 Oct; 138(17):1628-1636. PubMed ID: 34269803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.
    Lin TS; Zahrieh D; Weller E; Alyea EP; Antin JH; Soiffer RJ
    Transplantation; 2002 Jul; 74(1):49-54. PubMed ID: 12134098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation.
    Borchers S; Luther S; Lips U; Hahn N; Kontsendorn J; Stadler M; Buchholz S; Diedrich H; Eder M; Koehl U; Ganser A; Mischak-Weissinger E
    Transpl Infect Dis; 2011 Jun; 13(3):222-36. PubMed ID: 21585633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
    Almyroudis NG; Jakubowski A; Jaffe D; Sepkowitz K; Pamer E; O'Reilly RJ; Papanicolaou GA
    Transpl Infect Dis; 2007 Dec; 9(4):286-94. PubMed ID: 17511819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon gamma 13-CA-repeat homozygous genotype and a low proportion of CD4(+) lymphocytes are independent risk factors for cytomegalovirus reactivation with a high number of copies in hematopoietic stem cell transplantation recipients.
    Jaskula E; Dlubek D; Duda D; Bogunia-Kubik K; Mlynarczewska A; Lange A
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1296-305. PubMed ID: 19747638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MICB Genetic Variants and Its Protein Soluble Level Are Associated with the Risk of Chronic GvHD and CMV Infection after Allogeneic HSCT.
    Siemaszko J; Dratwa M; Szeremet A; Majcherek M; Czyż A; Sobczyk-Kruszelnicka M; Fidyk W; Solarska I; Nasiłowska-Adamska B; Skowrońska P; Bieniaszewska M; Tomaszewska A; Basak GW; Giebel S; Wróbel T; Bogunia-Kubik K
    Arch Immunol Ther Exp (Warsz); 2024 Jan; 72(1):. PubMed ID: 38847554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of effector memory Vδ2
    Huang Y; Jiang C; Zhu J; Lin L; Mao M; Yin T; Cai G
    Front Immunol; 2024; 15():1397483. PubMed ID: 38915409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus Infection Post-Allogeneic Stem Cell Transplantation: Experience from a Country with High Seropositivity.
    Iftikhar R; Farhan M; Khan M; Chaudhry QUN; Ghafoor T; Shahbaz N; Khan MA; Khattak TA; Rehman J; Humayun S; Majeed A
    Transplant Cell Ther; 2023 Aug; 29(8):521.e1-521.e7. PubMed ID: 37164292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation.
    Cunha C; Aversa F; Lacerda JF; Busca A; Kurzai O; Grube M; Löffler J; Maertens JA; Bell AS; Inforzato A; Barbati E; Almeida B; Santos e Sousa P; Barbui A; Potenza L; Caira M; Rodrigues F; Salvatori G; Pagano L; Luppi M; Mantovani A; Velardi A; Romani L; Carvalho A
    N Engl J Med; 2014 Jan; 370(5):421-32. PubMed ID: 24476432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status.
    Servais S; Dumontier N; Biard L; Schnepf N; Resche-Rigon M; Peffault de Latour R; Scieux C; Robin M; Meunier M; Xhaard A; Sicre de Fontbrune F; Le Goff J; Socié G; Simon F; Mazeron MC
    Clin Microbiol Infect; 2016 Mar; 22(3):289.e1-7. PubMed ID: 26627339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus.
    Liu YC; Lu PL; Hsiao HH; Chang CS; Liu TC; Yang WC; Lin SF
    Ann Hematol; 2012 Apr; 91(4):587-95. PubMed ID: 21997849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation in Malignancies: Proposal for Classification.
    Dziedzic M; Sadowska-Krawczenko I; Styczynski J
    Anticancer Res; 2017 Dec; 37(12):6551-6556. PubMed ID: 29187429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation.
    Lugthart G; van Ostaijen-Ten Dam MM; Jol-van der Zijde CM; van Holten TC; Kester MG; Heemskerk MH; Bredius RG; van Tol MJ; Lankester AC
    Biol Blood Marrow Transplant; 2014 May; 20(5):655-61. PubMed ID: 24462981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unravelling the potential of TIM-3 gene polymorphism in allogeneic hematopoietic stem cell transplantation - a preliminary study.
    Biały S; Siemaszko J; Sobczyk-Kruszelnicka M; Fidyk W; Solarska I; Nasiłowska-Adamska B; Skowrońska P; Bieniaszewska M; Tomaszewska A; Basak GW; Giebel S; Wróbel T; Bogunia-Kubik K
    Transpl Immunol; 2024 Aug; 85():102084. PubMed ID: 38992477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study.
    Serio B; Giudice V; Guariglia R; Fontana R; Pezzullo L; Martorelli MC; Ferrara I; Mettivier L; D'Addona M; Vaccaro E; Langella M; Selleri C
    Infez Med; 2021 Mar; 29(1):102-113. PubMed ID: 33664179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
    Kielsen K; Enevold C; Heilmann C; Sengeløv H; Pedersen AE; Ryder LP; Müller K
    Front Immunol; 2018; 9():109. PubMed ID: 29456530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of ATG abrogates the antileukemic effect of cytomegalovirus reactivation in patients with acute myeloid leukemia receiving grafts from unrelated donors.
    Busca A; Passera R; Pini M; Zallio F; Dellacasa C; Audisio E; Giaccone L; Maffini E; Costa C; Cavallo R; Bruno B
    Am J Hematol; 2015 Jun; 90(6):E117-21. PubMed ID: 25752810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.